From New Castle to Sussex counties, holiday pop-up bars bring new menus, selfie stations, themed parties and plenty of spirit ...

Activist Irenic Capital Management said Tuesday that it would back fellow dissident Starboard Value’s push to dissolve the ...

Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist ...

We warn against buying Autodesk shares due to inflated valuation after activist campaign; recommends selling. Read an ...

Kenvue Inc., the owner of Tylenol and Neutrogena, reported sales that trailed estimates after its skin health and beauty ...

NEW YORK, Oct 22 (Reuters) - Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's (PFE.N), opens new tab board needs to hold management accountable ...

In a Tuesday interview with CNBC's Jim Cramer, Pfizer CEO Albert Bourla struck a positive tone about activist investor ...

He also shared a version of the presentation his hedge fund Starboard presented to Pfizer officials at a meeting last week. "It's not often that investors and shareholders are able to see what we ...

The decision to sell is not final, and Pfizer could eventually choose to keep the unit, the sources said. UPDATED: Starboard ...

Starboard Value just shook things up, taking a bold stake in Kenvue (NYSE:KVUE), the company behind everyday staples like Band-Aid, Listerine, and Tylenol. Since breaking away from Johnson ...

Activist investor Starboard Value has sharpened its criticism of Pfizer Inc. (NYSE:PFE), holding the pharmaceutical giant’s management accountable for failing to deliver on its promises of ...

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job. Starboard has called on Pfizer’s board to “hold management ...